This is a non-core endpoint: only basic statistics are computed.
Endpoint definition
↥392423 individuals
Apply sex-specific rule None
392423
Check conditions None
392423
Check pre-conditions, main-only, mode, registry filters
2 out of 7 registries used, show all original rules.
54
Check minimum number of events None
54
Include endpoints None
54
Remove individuals based on genotype QC
54
Control definitions
Controls for this endpoint are individuals that are not cases.
Extra metadata
Show upset plot detailing case counts by codes
Or the full data table
Similar endpoints
↥List of similar endpoints to Melanoma in situ of scalp and neck based on the number of shared cases.
Broader endpoints:
- Melanoma in situ of scalp and neck (controls excluding all cancers)
- Melanoma in situ (controls excluding all cancers)
- Melanoma in situ
- Malignant melanoma
- Malignant melanoma (controls excluding all cancers)
Narrower endpoints:
Summary Statistics
↥Key figures
All | Female | Male | |
---|---|---|---|
Number of individuals | 54 | 15 | 39 |
Unadjusted prevalence (%) | 0.01 | 0.01 | 0.02 |
Mean age at first event (years) | 69.45 | 70.23 | 69.14 |
Mortality
Not a core endpoint, no data to show.
Age distribution of first events
Year distribution of first events
Cumulative Incidence
Not a core endpoint, no data to show.
Correlations
↥
Index endpoint: CD2_INSITU_MELANOMA_SCALPNECK – Melanoma in situ of scalp and neck
GWS hits:
Survival analyses between endpoints
↥Not a core endpoint, no data to show.
Drugs most likely to be purchased after Melanoma in situ of scalp and neck
↥Endpoint not on priority list, no data to show.